COCRYSTAL PHARMA INC - COM (COCP)

CUSIP: 19188J300

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
5,523,481
Share change
+997,827
Total reported value
$8,392,000
Price per share
$1.52
Number of holders
20
Value change
+$2,045,321
Number of buys
10
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 19188J300?
CUSIP 19188J300 identifies COCP - COCRYSTAL PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of COCRYSTAL PHARMA INC - COM (COCP) as of Q2 2020

As of 30 Jun 2020, COCRYSTAL PHARMA INC - COM (COCP) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,523,481 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, EMORY UNIVERSITY, Parallel Advisors, LLC, BANK OF AMERICA CORP /DE/, NORTHERN TRUST CORP, Verition Fund Management LLC, and Qube Research & Technologies Ltd. This page lists 20 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.